Aiha - warm autoimmune hemolytic anemia
Clinical trials for Aiha - warm autoimmune hemolytic anemia explained in plain language.
Never miss a new study
Get alerted when new Aiha - warm autoimmune hemolytic anemia trials appear
Sign up with your email to follow new studies for Aiha - warm autoimmune hemolytic anemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug OM336 aims to tame overactive immune system
Disease control Recruiting nowThis early-phase trial tests a new drug called OM336 in 32 adults with autoimmune cytopenias, conditions where the immune system attacks blood cells. The study focuses on safety and how the drug moves through the body, not yet on curing the disease. Participants must have tried a…
Matched conditions: AIHA - WARM AUTOIMMUNE HEMOLYTIC ANEMIA
Phase 1 • Sponsor: Lakefront Biotherapeutics West LLC • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Engineered immune cells take on tough blood disorder
Disease control Recruiting nowThis early-stage study tests a new treatment for people with a severe type of autoimmune hemolytic anemia (AIHA) that hasn't improved after at least three prior therapies. The treatment uses specially engineered immune cells (CAR-T cells) from a healthy donor to target and destro…
Matched conditions: AIHA - WARM AUTOIMMUNE HEMOLYTIC ANEMIA
Early phase 1 • Sponsor: The Second Hospital of Anhui Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC